Clinical Trial Update: Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication [NA]

View source ↗

Summary

This clinical trial update from Icahn School of Medicine at Mount Sinai investigates reducing the duration of untreated psychosis in the United States through s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinical High Risk For Psychosis
• First Episode Psychosis

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: First Episode Psychosis (FEP), Clinical High Risk for Psychosis (CHR) | NA | Status: ENROLLING_BY_INVITATION